Studies have found that PDGF and PDGFRβ levels are increased in both the plasma and cerebrospinal fluid (CSF) of AD patients (Sil et al., 2018), suggesting a role for this axis in AD pathogenesis. This evidence concerns the gene PDGFRB and Alzheimer disease.